As societal attitudes and legislative landscapes regarding cannabis evolve, the potential for federal legalization looms. This shift, particularly if the drug's scheduling moves from Schedule I to Schedule III, could greatly benefit multi-state operators in the cannabis sector.
With medical cannabis legalized in 38 states currently, the market is expected to grow significantly in the upcoming years. BDSA, a leading cannabis industry market intelligence platform, anticipates U.S. cannabis sales to skyrocket to $32.4 billion this year and reach $46 billion by 2028, driven notably by the adult-use segment.
